Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis
Authors
Keywords
-
Journal
Transplant Infectious Disease
Volume 17, Issue 2, Pages 163-173
Publisher
Wiley
Online
2015-02-07
DOI
10.1111/tid.12349
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Valganciclovir Plus Cytomegalovirus Immune Globulin for Prevention of Cytomegalovirus Disease in High-Risk Renal Transplant Recipients
- (2014) Angela Q. Maldonado et al. ANNALS OF PHARMACOTHERAPY
- Cytomegalovirus in Solid Organ Transplantation
- (2013) R. R. Razonable et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Electronic Estimations of Renal Function Are Inaccurate in Solid-Organ Transplant Recipients and Can Result in Significant Underdosing of Prophylactic Valganciclovir
- (2013) J. Trevillyan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantation
- (2013) M.A. Posadas Salas et al. Transplant Infectious Disease
- Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment
- (2012) Elena Beam et al. Current Infectious Disease Reports
- Impact of Cytomegalovirus Disease in D+/R- Kidney Transplant Patients Receiving 6 Months Low-Dose Valganciclovir Prophylaxis
- (2011) F. L. Luan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Comparative Evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) Study Equation for Drug Dosing: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy
- (2011) Heather A Nyman et al. PHARMACOTHERAPY
- The risk of cytomegalovirus recurrence after kidney transplantation
- (2011) Ilkka Helanterä et al. TRANSPLANT INTERNATIONAL
- The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
- (2010) A. Humar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effectiveness of Valganciclovir 900 mg versus 450 mg for Cytomegalovirus Prophylaxis in Transplantation: Direct and Indirect Treatment Comparison Meta-analysis
- (2010) A. C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study
- (2010) Oriol Manuel et al. CLINICAL TRANSPLANTATION
- New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation
- (2010) Albert J. Eid et al. DRUGS
- Defining the Risks for Cytomegalovirus Infection and Disease After Solid Organ Transplantation
- (2010) Robert J Stratta et al. PHARMACOTHERAPY
- Direct and indirect effects of cytomegalovirus: can we prevent them?
- (2009) Raymund Razonable ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Six-Month Prophylaxis Is Cost Effective in Transplant Patients at High Risk for Cytomegalovirus Infection
- (2009) F. L. Luan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Prevention of Cytomegalovirus Disease in Renal Transplantation: Single-Center Experience
- (2009) L. Parreira et al. TRANSPLANTATION PROCEEDINGS
- Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients
- (2008) C. E. Chamberlain et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
- (2008) K. Solez et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Selective low-dose valganciclovir for prevention of cytomegalovirus disease following kidney transplantation
- (2008) Yafit Partouche Avidan et al. JOURNAL OF INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now